Price target
0.860.000.00%
The 5 analysts offering 1 year price forecasts for 61Y have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to 61Y in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
61Y EPS for the last quarter is −0.38 EUR despite the estimation of −0.37 EUR. In the next quarter EPS is expected to reach −0.32 EUR. Track more of MARINUS PHARMAC. DL-,001 financials and stay on top of what is up with the company.
In the next quarter MARINUS PHARMAC. DL-,001 revenue is expected to reach 10.23 M EUR. Check out MARINUS PHARMAC. DL-,001 revenue and earnings and make informed decisions.
According to analysts, 61Y price target is 0.86 EUR with a max estimate of 1.91 EUR and a min estimate of 0.29 EUR. Check if this forecast comes true in a year, meanwhile watch MARINUS PHARMAC. DL-,001 stock price chart and keep track of the current situation with 61Y news and stock market news.
We've gathered opinions of 6 analysts rating 61Y stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.